VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 367 filers reported holding VANECK VECTORS ETF TR in Q3 2016. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $337,248 | -59.4% | 10,425 | -63.2% | 0.05% | -68.7% |
Q4 2019 | $830,000 | +2.6% | 28,351 | -6.4% | 0.16% | -6.3% |
Q3 2019 | $809,000 | +4.5% | 30,290 | 0.0% | 0.17% | -6.5% |
Q2 2019 | $774,000 | +6.8% | 30,290 | -6.3% | 0.19% | -8.4% |
Q1 2019 | $725,000 | +4.5% | 32,328 | -1.7% | 0.20% | -21.6% |
Q4 2018 | $694,000 | +11.6% | 32,900 | -2.0% | 0.26% | +32.8% |
Q3 2018 | $622,000 | -12.4% | 33,588 | +5.6% | 0.20% | -22.0% |
Q2 2018 | $710,000 | +0.7% | 31,802 | -0.9% | 0.25% | +18.5% |
Q1 2018 | $705,000 | -8.1% | 32,077 | -2.8% | 0.21% | -8.7% |
Q4 2017 | $767,000 | -9.2% | 32,991 | -10.3% | 0.23% | +12.1% |
Q3 2017 | $845,000 | +3.6% | 36,796 | -0.5% | 0.21% | -2.4% |
Q2 2017 | $816,000 | -4.0% | 36,967 | -0.8% | 0.21% | -11.0% |
Q1 2017 | $850,000 | +5.6% | 37,267 | -3.2% | 0.24% | -2.9% |
Q4 2016 | $805,000 | -23.0% | 38,486 | -2.8% | 0.24% | -19.7% |
Q3 2016 | $1,046,000 | – | 39,591 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $25,094,000 | 16.41% |
Windmill Hill Asset Management Ltd | 844,600 | $28,700,000 | 15.26% |
Hollow Brook Wealth Management LLC | 671,454 | $22,816,000 | 14.18% |
New Harbor Financial Group, LLC | 1,167,112 | $39,658,000 | 13.37% |
Grand Central Investment Group | 423,252 | $14,382,000 | 12.82% |
New Harbor Financial Group, LLC | 1,101,300 | $37,422,000 | 12.62% |
Cadence Wealth Management LLC | 432,124 | $14,684,000 | 12.40% |
Bienville Capital Management, LLC | 4,007,300 | $136,168,000 | 11.31% |
ONE PLUS ONE WEALTH MANAGEMENT, LLC | 460,504 | $15,648,000 | 10.79% |
Plaisance Capital LLC | 608,000 | $20,660,000 | 10.29% |